Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
6
Bullish
6
Bearish
21
Neutral
6
Bullish
19
Bearish
19
Neutral
0
Bullish
13
Investor Presentation
Q3 FY24
Investor Presentation
Q2 FY23
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Market Cap
₹ 418 Cr
P/E
36.74
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
418 Cr
Low Risk
36.7
30.8
1.3
6.3
79.78
35.00
Sales CAGR
1Y
4.15%
3Y
7.64%
5Y
11.23%
10Y
8.84%
Profit CAGR
1Y
21.71%
3Y
28.01%
5Y
44.00%
10Y
27.55%
ROE
TTM
16.97%
3Y
16.15%
5Y
14.50%
10Y
11.70%
ROCE
TTM
20.65%
3Y
23.27%
5Y
20.70%
10Y
17.09%
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 10.29 L in last 5 Years